Create Health Ventures, which focuses on investing in early-stage digital health companies for payers and pharmaceutical companies with founders with experience in the healthcare industry, announced the launch after closing its first fund of $21 million.
The venture capital firm will invest in startups that offer payer and pharmaceutical focused B2B platforms that aim to improve patient engagement and the patient care journey, including clinical trial recruitment and retention.
“We’re hearing directly from payers, healthcare providers and pharmaceutical companies that their business objectives are to enhance the patient experience, drive better health outcomes and improve access to healthcare for all, especially those with health disparities,” Emma Cartmell, co-founder and managing partner at Create Health Ventures, said in a statement.
“Healthcare founders know how to leverage technology to address these challenges, and we know supporting them is the most powerful way we can invest in and positively impact the healthcare industry.”
Larger trends
Other venture firms focused on funding digital health companies that have emerged in the past year include Amboy Street Ventures, which was founded in 2023 after launching a $20 million fund to invest in women’s health and sexual health.
Earlier this year, health tech investor Transcurrent CEO Glenn Talman has launched a new $100 million venture fund called 62 Ventures, which will invest in startups outside of the strictly digital health space of his existing fund, 7wire Ventures.
62 Ventures will focus on education, health, caregiving, environmental sustainability and other industries.
Last year, Thalmann’s 7wire Ventures has raised its largest fund to date, closing a $217 million fund and increasing assets under management to $500 million.
The company said one-third of the funds raised will be used to fund Series B and Series C rounds that are not already in the company’s portfolio.
